LPCH Stanford /ID# 163337 — Palo Alto, California

LPCH Stanford /ID# 163337 is a clinical research site located in Palo Alto, California, United States 94304.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

LPCH Stanford /ID# 163337 has participated in 1 clinical trials.

Therapeutic areas: Acute Lymphoblastic Leukemia (ALL), Lymphoblastic Lymphoma.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for LPCH Stanford /ID# 163337?

LPCH Stanford /ID# 163337 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has LPCH Stanford /ID# 163337 conducted?

LPCH Stanford /ID# 163337 has 1 clinical trials on record. Their work covers Acute Lymphoblastic Leukemia (ALL), Lymphoblastic Lymphoma.

Is LPCH Stanford /ID# 163337 accredited by Crixeo Health?

LPCH Stanford /ID# 163337 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about LPCH Stanford /ID# 163337?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.